Mata, you are the only reason why I even check this board. Thanks for your important contributions. (I see that yahoo finance has a message board for BOCX fans as well). It appears good things seem to be happening, so I will continue to be patient. No one is selling except the illusion can be created by those lowlife manipulators. This year is pivotal to the future of Biocurex. I assume data is being collected to present to the FDA as sighted on the BOCX website as one of the company's main objectives. FDA approval IMO should precede another licensing agreement unless that licensee is flipping the bill. They need to have a product to launch and that should have always been their #1 focus. Otherwise the licensees are there to sell what? They are the marketers and distributors. No one makes money w/o a product. Now that management realizes monitoring is their best shot I hope they are working feverishly collecting sufficient data to move forward with the 510k. After monitoring is approved THEN move forward with FDA approval on POC device. The POC device should be in development now, and should be ready to roll just after the monitoring application is approved to get the product out into the medical field. This year is presently over half over and I'm sure investors would love to see an application with the FDA soon.
News 
Market Data 
Discover 
AI
